Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship
Linwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2006
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma
Ewa Mrozek, Richard T Kloos, Matthew D Ringel, et al.
JNCI Cancer Spectrum
|
September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populations
Wayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer
Jian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>
Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 28, 2012
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring
Aubrey A Carhill, Maria E Cabanillas, Camilo Jimenez, et al.
Head & Neck
|
April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
Gary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer
|
April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)
Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 27, 2010
Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer
Michael B Bass, Steven I Sherman, Martin J Schlumberger, et al.
The New England Journal of Medicine
|
July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
Archives of Surgery (Chicago, Ill. : 1960)
|
April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship
Linwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2006
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma
Ewa Mrozek, Richard T Kloos, Matthew D Ringel, et al.
JNCI Cancer Spectrum
|
September 13, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populations
Wayne Y Wu, Brian Luke, Xiao-Cheng Wu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer
Jian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>
Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 28, 2012
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring
Aubrey A Carhill, Maria E Cabanillas, Camilo Jimenez, et al.
Head & Neck
|
April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
Gary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer
|
April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)
Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 27, 2010
Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer
Michael B Bass, Steven I Sherman, Martin J Schlumberger, et al.
The New England Journal of Medicine
|
July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.
Page
of 15